Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
Procysbi (cysteamine bitartrate delayed-release capsules; Raptor) has been made available for the management of nephropathic cystinosis.
Insulin-like peptide 3 levels are decreased in cryptorchidism and correlate negatively with bisphenol A.
Outcomes are similar between men with histologically comparable prostate cancer who receive a radical prostatectomy after a period of active surveillance and those with low-risk disease who undergo immediate prostatectomy.
Care coordination, enhanced using an electronic health record system, can reduce the number of health care visits needed for the work-up of hematuria.
Converting a urology practice to an integrated prostate cancer center (IPCC) results in greater use of intensity modulated radiation therapy and lower use of androgen deprivation therapy.
This activity will review how to differentiate between different types of urinary incontience (UI). Through the use of a case study, the approaches to diagnosing and managing UI will be discussed. It is accredited for 1.00 CNE credit of which 0.50 is pharmacology credit.1.00 CE for Nurses
This activity will discuss a review of the symptoms associated with STIs and the latest techniques in the diagnosis and management of STIs. This activity is accredited for 1.00 CNE credit of which 0.50 is pharmacology credit.1.00 CE for Nurses
From the June 2013 Renal & Urology News. In this article, we review some of the key aspects of bone health that urologists should take into consideration when managing PCa patients.1.00 AMA PRA Category 1 Credit(s)TM